[17] There is no official link established between GLP-1 use and specific adverse effects in breastfed infants , primarily because robust human studies have not been conducted
Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity Diabetes Care
GLP-1R KO can lead to increased appetite, contributing to weight gain
By slowing digestion and signaling fullness to the brain, GLP-1s help reduce cravings, improve blood sugar control, and support sustainable weight loss
We recommend what aligns with your health history, goals, lifestyle, and risk tolerance: For proven, accessible metabolic support Tirzepatide For cutting-edge potential and deeper metabolic impact (with understanding of investigational status) Retatrutide Always under personalized, science-backed, whole-body care.
These included: Nausea (the most frequently reported adverse effect) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent, occurring more frequently and with greater severity at higher doses